Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORTICOP: Corticosteroids vs placebo for ventilatory support duration in severe COPD exacerbations in ICU
2024-516651-41-00Phase 3Completed
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Methylprednisolone arm with Placebo arm (2 arms). Primary endpoint: Ventilator-free days and alive. Started Sep 2024; status: completed.
02
Drugs
methylprednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2024-516651-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516651-41-00.